Avalo Therapeutics, Inc. AVTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Avalo Therapeutics, Inc. (AVTX), dont 29 achats et 17 ventes. Le total des achats d'initiés s'élève à $18.97M et le total des ventes d'initiés à $848.54K.

Les initiés notables ayant une activité récente comprennent Sullivan Christopher Ryan, Doyle Mittie, Lind Kevin Robert. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — AVTX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-02	Sullivan Christopher Ryan	Chief Financial Officer	Vente Informative	1,780	$17.57	$31.27K	17,338
2026-04-01	Sullivan Christopher Ryan	Chief Financial Officer	Vente Informative	7,479	$16.83	$125.84K	25,318
2026-04-01	Doyle Mittie	Chief Medical Officer	Vente Informative	679	$16.00	$10.86K	3,622
2026-03-31	Lind Kevin Robert	Director	Attribution de RSU	1,370	$14.93	$20.45K	1,370
2026-03-31	Jain Rita	Director	Attribution de RSU	1,339	$14.93	$19.99K	1,339
2026-03-28	Kaplan Gilla	Director	Exercice d'Options (Vente)	3,166	-	-	3,167
2026-03-28	Neil Garry Arthur	Chief Executive Officer	Exercice d'Options (Vente)	64,866	-	-	64,867
2026-03-28	Chan Mitchell	Director	Exercice d'Options (Vente)	3,166	-	-	3,167
2026-03-28	Sullivan Christopher Ryan	Chief Financial Officer	Exercice d'Options (Vente)	24,200	-	-	24,200
2026-03-28	Kantoff Aaron	Director	Exercice d'Options (Vente)	3,166	-	-	3,167
2026-03-28	Goldman Jonathan	Director	Exercice d'Options	3,166	-	-	3,166
2026-03-28	Truex Samantha	Director	Exercice d'Options (Vente)	3,166	-	-	3,167
2026-03-16	Doyle Mittie	Chief Medical Officer	Vente Informative	25,492	$16.15	$411.61K	3,622
2026-02-26	Neil Garry Arthur	Chief Executive Officer	Attribution de RSU	286,000	$17.64	$5.05M	286,000
2026-02-26	Varki Paul	Chief Legal Officer	Attribution de RSU	80,000	$17.64	$1.41M	80,000
2026-02-26	Sullivan Christopher Ryan	Chief Financial Officer	Attribution de RSU	105,000	$17.64	$1.85M	105,000
2026-02-26	Doyle Mittie	Chief Medical Officer	Attribution de RSU	105,000	$17.64	$1.85M	105,000
2026-02-26	Riley Jennifer	Chief Strategy Officer	Attribution de RSU	95,000	$17.64	$1.68M	95,000
2026-02-26	Boyd Taylor	Chief Business Officer	Attribution de RSU	95,000	$17.64	$1.68M	95,000
2025-12-31	Lind Kevin Robert	Director	Attribution de RSU	848	$18.16	$15.4K	848
2025-12-31	Jain Rita	Director	Attribution de RSU	1,043	$18.16	$18.94K	1,043
2025-12-10	Varki Paul	Chief Legal Officer	Retenue Fiscale RSU	1,016	$4.10	$4.17K	3,634
2025-12-10	Sullivan Christopher Ryan	Chief Financial Officer	Retenue Fiscale RSU	155	$4.10	$635.50	17,338
2025-12-10	Doyle Mittie	Chief Medical Officer	Retenue Fiscale RSU	1,013	$4.10	$4.15K	3,622
2025-12-10	Riley Jennifer	Chief Strategy Officer	Retenue Fiscale RSU	637	$4.10	$2.61K	2,655
2025-11-14	Goldman Jonathan	Director	Vente Informative	3,167	$14.30	$45.29K	-
2025-10-01	Lind Kevin Robert	Director	Inconnu	-	-	-	-
2025-10-01	Lind Kevin Robert	Director	Attribution de RSU	40,200	$12.96	$520.99K	40,200
2025-10-01	Boyd Taylor	Officer	Inconnu	-	-	-	-
2025-10-01	Boyd Taylor	Chief Business Officer	Attribution de RSU	275,000	$12.96	$3.56M	275,000
2025-09-30	Jain Rita	Director	Attribution de RSU	1,572	$12.71	$19.98K	1,572
2025-06-17	Kaplan Gilla	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-06-17	Heffernan Michael Thomas	Director	Attribution de RSU	29,500	$4.47	$131.87K	29,500
2025-06-17	Almenoff June Sherie	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-06-17	Jain Rita	Director	Inconnu	-	-	-	-
2025-06-17	Jain Rita	Director	Attribution de RSU	40,200	$4.47	$179.69K	40,200
2025-06-17	Chan Mitchell	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-06-17	Kantoff Aaron	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-06-17	Goldman Jonathan	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-06-17	Truex Samantha	Director	Attribution de RSU	20,100	$4.47	$89.85K	20,100
2025-03-28	Kaplan Gilla	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-28	Almenoff June Sherie	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-28	Neil Garry Arthur	Chief Executive Officer	Retenue Fiscale RSU	17,787	$8.46	$150.48K	47,140
2025-03-28	Chan Mitchell	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-28	Sullivan Christopher Ryan	Chief Financial Officer	Retenue Fiscale RSU	7,285	$8.46	$61.63K	16,921
2025-03-28	Kantoff Aaron	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-28	Goldman Jonathan	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-28	Truex Samantha	Director	Exercice d'Options	3,167	-	-	3,167
2025-03-25	Heffernan Michael Thomas	Director	Inconnu	-	-	-	-
2025-03-25	Heffernan Michael Thomas	Director	Attribution de RSU	50,000	$8.54	$427K	50,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration